Asia Pacific Protein Engineering Market

Asia Pacific Protein Engineering Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, and Software & Services), By End-use, By Technology, By Protein Type, By Country and Growth Forecast, 2024 - 2031

Report Id: KBV-23185 Publication Date: June-2024 Number of Pages: 148
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Protein Engineering Market would witness market growth of 16.7% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $544.2 million by 2031. The Japan market is registering a CAGR of 15.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 17.4% during (2024 - 2031).

Asia Pacific Protein Engineering Market

Protein engineering has made it possible for industrial biotechnology to take advantage of novel opportunities to enhance the efficiency and sustainability of a wide variety of industrial processes. Engineered enzymes are at the forefront of this revolution, finding applications in biofuel production, bioplastics synthesis, and food processing. As biological catalysts, enzymes offer remarkable specificity and efficiency, making them ideal for industrial applications.

Similarly, this engineering has greatly benefited the production of bioplastics derived from biodegradable renewable resources. By engineering enzymes that facilitate the polymerization of lactic acid into polylactic acid (PLA), a common bioplastic, researchers have developed more efficient and sustainable production processes. This innovation addresses the growing environmental concerns associated with conventional plastics, offering a greener alternative that reduces reliance on fossil fuels and minimizes plastic pollution.

The growing prevalence of chronic diseases in India is a driving force behind the demand for engineering solutions. According to estimates provided by the Indian Council of Medical Research, chronic diseases are responsible for approximately sixty percent of all deaths that occur in India. Among these, diabetes, cancer, and cardiovascular diseases are the most prevalent. As a result, engineering products and technologies have a substantial market opportunity to develop novel diagnostics and therapeutics for these diseases. Waste treatment is another area where this engineering is making a significant impact in this region. Engineered enzymes enhance the breakdown of organic waste in wastewater treatment plants. This not only improves the efficiency of waste treatment but also reduces the environmental footprint of these processes. In Japan, companies like Hitachi Zosen Corporation are developing advanced wastewater treatment systems that utilize engineered enzymes to degrade organic pollutants more effectively. Hence, the aforementioned trends will spur the expansion of the market throughout the forecast period.

Free Valuable Insights: The Global Protein Engineering Market is Predict to reach USD 7.8 Billion by 2031, at a CAGR of 16.0%

Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Genscript Biotech Corporation
  • Amgen, Inc.
  • Promega Corporation

Asia Pacific Protein Engineering Market Report Segmentation

By Product

  • Instruments
  • Reagents
  • Software & Services

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic Research Institutes

By Technology

  • Rational Protein Design
  • Hybrid Approach
  • Directed Evolution
  • De Novo Protein Design
  • Others

By Protein Type

  • Monoclonal Antibodies
  • Insulin
  • Vaccines
  • Growth Factors
  • Interferon
  • Colony Stimulating Factors
  • Coagulation Factors
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo